My guess is they'll have 3 sites in The US (the minimum stipulated by FDA for the trial) and also 3 sites in Australia (the same 3 sites which have been used in the ongoing trials to date, so sites which are very familiar with the EMV tech, The EMU.)
6 sites, 350+ patients (I know minimum 300, my guess is 350+,) so an average of 60 patients per site, they will get it done quickly.
Although as always, we'll have to wait and see!
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-15
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
-0.005(0.28%) |
Mkt cap ! $156.0M | |||
| Open | High | Low | Value | Volume |
| $1.78 | $1.83 | $1.76 | $36.71K | 20.53K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1594 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.79 | 2400 | 2 |
View Market Depth
| Last trade - 12.07pm 18/06/2025 (20 minute delay) ? |
| EMV (ASX) Chart |